Subscribe to RSS
DOI: 10.1055/s-0038-1654532
Inhibition of Clotting as the Result of Plasminogen Activation by Streptokinase
II. Analytical Studies of the Clotting MechanismPublication History
Publication Date:
17 June 2018 (online)
Summary
Investigations of the clotting mechanism were carried out by lysis time determinations when plasminogen was activated by streptokinase and the following results were obtained:
1. The recalcification time during the period of activation showed an initial decrease of the clotting time, followed by a prolongation.
The thrombin time method showed only a prolongation up to the moment when inhibition of coagulation occurred.
2. The clotting factors II, V, VII, VIII and IX remained unaffected in this system.
3. The clotting activity, as well as the time required for the inhibition of coagulation, were dependent on the streptokinase concentration on the one hand, and on the fibrinogen concentration on the other.
4. An antithrombin-like inhibitor could be excluded as the cause of incoagulability.
5. In our system, inhibition of coagulation was caused by fibrinogenolysis, by which fibrinogen was altered to a biologically inactive globulin. The latter could still be demonstrated in large amounts by means of certain protein estimations. But the proteolytic activity is assumed to be not strong enough to destroy the other clotting factors as well.
This system is, therefore, especially useful for studying the isolated “anti-fibrinogenic“ effect of plasmin.
-
References
- (1) Alagille C, Soulier J. P. Action des enzymes protéolytiques sur le sang total in vitro. Modifications des facteurs de coagulation et du complément. Sem. Hôp. Paris 32: 355 1956;
- (2) Astrup T. Personal communication..
- (3) Beller F. K. Die Gerinnungsverhältnisse bei der Schwangeren und beim Neugeborenen. Barth; Leipzig: 1957
- (4) Beller F. K, Glas P. Ungerinnbarkeit des Blutes als Folge der Plasminogenaktivierung. Naturwissenschaften 46: 476 1959;
- (5) Beller F. K, Schumacher G. Über die Kombination von fibrinolytischer und Antikoagulantientherapie. Dtsch. med. Wschr. 48: 2029-2031 1957;
- (6) Cliffton E. E. The Use of Plasmin in Humans. Ann. N. Y. Acad. Sci. 68: 209 1957;
- (7) Coon W. W, Duff I. F. Effects of Intravenous Human Plasmin on the Blood Clotting Mechanism of the Dog. J. Lab. clin. Med. 51: 381 1958;
- (8) Deutsch E. Blutgerinnungsfaktoren. Deuticke; Wien: 1955
- (9) Deutsch E. Thrombose und Blutgerinnung unter besonderer Berücksichtigung der Prophylaxe. 7th Europ. Congr. of Haematol.. London: 1959
- (10) Deutsch E, Frischauf H. Untersuchung über die Wirkung des Trypsins auf die Blutgerinnung. Acta Haemat. (Basel) 13: 161 1955;
- (11) Ferguson J. H. Proc. Soc. exp. Biol. (N. Y.) 46: 80 1941;
- (12) Fletcher A. P, Alkjaersig N, Sherry S. The Maintenance of a Substained Thrombolytic State in Man. Induction and Effects. J. clin. Invest. 38 (07) 1096-1110 1959;
- (13) Glas P, Beller F. K. Inhibition of Clotting as the Result of Plasminogen Activation by Streptokinase. I. Thromb. Diath. haem. 4: 507 1960;
- (14) Hörder M. H, Kickhöfen B. Aktivierung der Fibrinolyse beim Menschen durch ein bakterielles Pyrogen. Klin. Wschr. 36: 164 1958;
- (15) Imhof P, Imhof M, Lauener St. Über die Aktivierung der Fibrinolyse durch Verabreichung von Nikotinsäure. J. suisse Méd. 89 (28) 736 1959;
- (16) Johnson S. A, Schneider Ch. L. The existence of antifibrinolytic activity in platelets. Science 117: 229 1953;
- (17) Jürgens J, Beller F. K. Klinische Methoden der Blutgerinnungsanalyse. G. Thieme; Stuttgart: 1959
- (18) von Kaulla K. N. Antikoagulantien und Fibrinolyse. Medizinische 51: 1651 1953;
- (19) Kowalski E. Montreux Conference of New Blood Clotting Factors. 1959 in press.
- (20) Lorand L. Interaction of Thrombin and Fibrinogen. Physiol. Rev. 34 (04) 742-752 1954;
- (21) De Nicola P. Thrombelastography. A. C. Thomas; Springfield: 1957
- (22) Niewiarowski S, Latallo Z. Influence of Plasmin on the First Coagulation Stage. Bull. Acad. Pol. Sci. Cl. II V 7-8 1957;
- (23) Niewiarowski S, Kowalski E. Antithrombin Formation during Proteolysis of Fibrinogen. Transact. 6th Congr. Europ. Soc. Flaematol. 158: 560 1957;
- (24) Niewiarowski S, Kowalski E. Un nouvel anticoagulant dérivé du fibrinogène. Rev. Hémat. 13 (03) 320 1958;
- (25) Ratnoff O. The effect of clotting on the spontaneous activation of plasmin. J. clin. Invest. 34: 958 1953;
- (26) Ratnoff O. Montreux Conference of New Blood Clotting Factor. 1959 in press.
- (27) Roemer H, Beller F. K. Die Störung der Blutgerinnung bei vorzeitiger Plazentalösung. Geburtsh. u. Frauenheilk. 1 1956;
- (28) Seegers W. H, Loomis E. C. Prothrombin and Fibrinolysis. Science 404: 461 1946;
- (29) Sherry S. The Fibrinolytic Activity of Streptokinase Activated Human Plasmin. J. clin. Invest. 33: 1054 1954;
- (30) Sherry S, Fletcher A. P, Alkjaersig N. Fibrinolysis and Fibrinolytic Activity. Physiol. Rev. 39 (02) 343-382 1959;
- (31) Soulier J. P, Alagille O, Larrieu M. J. Modification in vivo des Facteurs de Coagulation dans les Fibrinolyses. Sem. Hôp. Paris 32: 359 1956;
- (32) Stefanini N, Murphy J. S. Studies on Platelets. Human Platelets as Source of Antifibrinolysin. J. clin. Invest. 35: 355 1956;
- (33) Travis B. L, Ferguson J. H. J. clin. Invest. 30: 112 1951;
- (34) Vecchietti G. La fibrinolysi attivata con streptochinasi nel periodo post-operatorio. Riv. Ostet. Ginec. 9 (03) 137 1954;